C3 rs2230205: Understanding Complement Component 3 Variants
The rs2230205 variant is a single nucleotide polymorphism located within the C3 gene, which encodes a central protein of the human complement system. Research has investigated this variant for its potential role in modulating susceptibility to age-related macular degeneration (AMD), particularly in the context of neovascular disease.
What each genotype means
Common genetic profile
This is the most common genotype observed in many populations. Research into this specific variant has explored its potential role in modulating susceptibility to age-related macular degeneration, though findings remain complex and sometimes inconsistent across different ethnic groups.
This is the major homozygous genotype and is the most frequently observed in global populations.
Heterozygous genetic profile
Carrying one copy of the A allele and one copy of the G allele represents a heterozygous state for this variant. Studies have investigated whether this variant contributes to the regulation of the complement system, which is involved in the development of certain eye conditions, but the clinical significance of this specific genotype is not considered definitive.
This genotype is found in a significant portion of the population, with the A allele occurring at a minor allele frequency of approximately 0.05 to 0.21 depending on ancestry.
Minor allele homozygous profile
This genotype represents the homozygous state for the minor allele. While some research has examined this variant in the context of complement system activity and susceptibility to neovascular age-related macular degeneration, the evidence is mixed and often dependent on specific population backgrounds. It is not a diagnostic marker, and any concerns regarding eye health should be discussed with an ophthalmologist.
This is the least common genotype, occurring less frequently than the heterozygous or major homozygous states in most studied populations.
What is rs2230205?
The variant rs2230205 is a specific genetic change located on chromosome 19 within the C3 gene. In genetic databases, this SNP is identified by its position and the specific nucleotide substitution that occurs at this site. It is one of several variants within the C3 locus that researchers have examined to understand how genetic diversity influences the function of the immune system. Because it sits within a gene critical for immune regulation, scientists often study such variants to determine if they alter the protein's structure or the efficiency of its production. This variant is categorized as a trait-associated SNP, meaning it has been identified in studies looking for genetic markers that correlate with specific health conditions or physiological differences in human populations.
The Role of the C3 Gene
The C3 gene provides instructions for making the complement component 3 protein, which is a vital part of the body's complement system. This system is a group of proteins that work together to help the immune system identify and clear pathogens, such as bacteria and viruses, and remove damaged cells. C3 acts as a central hub; it is the most abundant complement protein in the blood and is essential for both the initiation and the amplification of the complement cascade. When the complement system is activated, C3 is cleaved into smaller fragments that trigger inflammation and help mark foreign invaders for destruction. Because of its central role, any variation that affects the expression or function of C3 can potentially influence how the body manages inflammation and tissue repair.
Research and AMD Associations
Scientific interest in rs2230205 stems largely from its potential link to age-related macular degeneration (AMD), a condition that affects the central part of the retina. The complement system is known to play a significant role in the pathogenesis of AMD, as chronic, low-level inflammation in the eye is a hallmark of the disease. Several studies have explored whether variants in C3, including rs2230205, contribute to an individual's risk of developing neovascular (wet) AMD. While some research has suggested a statistical association, the evidence is considered moderate. Furthermore, the impact of these variants can be complex and may vary significantly depending on an individual's ancestral background. It is important to note that genetic associations are statistical observations across large groups and do not predict an individual's health outcome.
Population Frequency
The frequency of the rs2230205 variant varies across different global populations. Current data indicates a minor allele frequency typically ranging between 0.05 and 0.12 in European and East Asian populations. This means that the variant is relatively common, though its prevalence is not uniform worldwide. Genetic studies often highlight that the risk profile associated with specific C3 variants can differ between ethnicities, which is a common theme in the study of complex, multifactorial diseases like AMD. Researchers continue to analyze these frequency differences to better understand the evolutionary history of these variants and their specific roles in human health across diverse ancestral groups.
Interpreting Genetic Information
Understanding your genetic information requires careful context. A variant like rs2230205 is just one of many factors—including age, environment, and lifestyle—that contribute to complex traits. Having a specific genotype does not mean you will develop a particular condition, nor does it guarantee protection. If you are concerned about your risk for eye health issues or other conditions, it is essential to consult with a healthcare professional, such as an ophthalmologist or a genetic counselor. They can provide personalized guidance based on your medical history and clinical symptoms. Never use genetic data to make medical decisions or change medications without professional supervision. Genetic testing results are best interpreted within the framework of a comprehensive clinical evaluation.
How common is this variant?
The minor allele frequency for rs2230205 is approximately 0.05 to 0.12 in European and East Asian populations.
Frequently asked questions
Is rs2230205 a diagnostic test for AMD?
No, rs2230205 is not a diagnostic test. AMD is a complex disease influenced by many genetic and environmental factors, and this variant only provides a small piece of the overall genetic picture.
Can I change my risk if I have the A allele?
Genetic variants are inherited and cannot be changed. However, you can focus on modifiable risk factors for eye health, such as maintaining a healthy diet, avoiding smoking, and scheduling regular eye exams with an eye care professional.
Why do studies show different results for this variant?
Genetic associations can vary due to differences in study design, sample sizes, and the ancestral backgrounds of the participants. This is common in research on complex diseases where many genes interact with each other and the environment.
Where can I find more information about my specific genetic results?
If you have received results from a genetic testing service, you should discuss them with a qualified healthcare provider or a genetic counselor. They can help you understand what the information means in the context of your personal and family health history.
Sources & further reading
Educational information only, last refreshed 9/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2230205?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in C3
This functional coding variant (Arg102Gly) in complement component 3 significantly elevates the risk of developing age-related macular degeneration.
Complement component 3 locus variant identified in genetic association studies of age-related macular degeneration and complement activation.
A low-frequency coding variant (p.Lys155Gln) in complement component 3 that confers significant risk for developing geographic atrophy and age-related macular degeneration.
Variant in complement component 3 associated with altered susceptibility to neovascular age-related macular degeneration.